scholarly journals A Genome Scan for Linkage With Aortic Root Diameter in Hypertensive African Americans and Whites in the Hypertension Genetic Epidemiology Network (HyperGEN) Study

2005 ◽  
Vol 18 (5) ◽  
pp. 627-632 ◽  
Author(s):  
A LYNCH ◽  
D ARNETT ◽  
L ATWOOD ◽  
R DEVEREUX ◽  
D KITZMAN ◽  
...  
2005 ◽  
Vol 20 (4) ◽  
pp. 712-718 ◽  
Author(s):  
B. I. Freedman ◽  
D. W. Bowden ◽  
S. S. Rich ◽  
C. J. Valis ◽  
M. M. Sale ◽  
...  

2004 ◽  
Vol 66 (4) ◽  
pp. 1517-1526 ◽  
Author(s):  
Donald W. Bowden ◽  
Carla J. Colicigno ◽  
Carl D. Langefeld ◽  
Michèle M. Sale ◽  
Adrienne Williams ◽  
...  

2011 ◽  
Vol 4 (1) ◽  
Author(s):  
Nathan E Wineinger ◽  
Amit Patki ◽  
Kristin J Meyers ◽  
Ulrich Broeckel ◽  
Charles C Gu ◽  
...  

1976 ◽  
Vol 17 (4) ◽  
pp. 465-470 ◽  
Author(s):  
Kotaro FURUKAWA ◽  
Junichi YOSHIKAWA ◽  
Kumeo TANAKA ◽  
Chujiro TANAKA ◽  
Seiki KAWAI ◽  
...  

animal ◽  
2019 ◽  
Vol 13 (4) ◽  
pp. 683-693 ◽  
Author(s):  
Z. Wang ◽  
H. Sun ◽  
Q. Chen ◽  
X. Zhang ◽  
Q. Wang ◽  
...  

2017 ◽  
Vol 117 (04) ◽  
pp. 758-768 ◽  
Author(s):  
Sebastian Armasu ◽  
Bryan McCauley ◽  
Iftikhar Kullo ◽  
Hugues Sicotte ◽  
Jyotishman Pathak ◽  
...  

SummaryTo identify novel single nucleotide polymorphisms (SNPs) associated with venous thromboembolism (VTE) in African-Americans (AAs), we performed a genome-wide association study (GWAS) of VTE in AAs using the Electronic Medical Records and Genomics (eMERGE) Network, comprised of seven sites each with DNA biobanks (total ~39,200 unique DNA samples) with genome-wide SNP data (imputed to 1000 Genomes Project cosmopolitan reference panel) and linked to electronic health records (EHRs). Using a validated EHR-driven phenotype extraction algorithm, we identified VTE cases and controls and tested for an association between each SNP and VTE using unconditional logistic regression, adjusted for age, sex, stroke, site-platform combination and sickle cell risk genotype. Among 393 AA VTE cases and 4,941 AA controls, three intragenic SNPs reached genome-wide significance: LEMD3 rs138916004 (OR=3.2; p=1.3E-08), LY86 rs3804476 (OR=1.8; p=2E-08) and LOC100130298 rs142143628 (OR=4.5; p=4.4E-08); all three SNPs validated using internal cross-validation, parametric bootstrap and meta-analysis methods. LEMD3 rs138916004 and LOC100130298 rs142143628 are only present in Africans (1000G data). LEMD3 showed a significant differential expression in both NCBI Gene Expression Omnibus (GEO) and the Mayo Clinic gene expression data, LOC100130298 showed a significant differential expression only in the GEO expression data, and LY86 showed a significant differential expression only in the Mayo expression data. LEMD3 encodes for an antagonist of TGF-β-induced cell proliferation arrest. LY86 encodes for MD-1 which down-regulates the pro-inflammatory response to lipopolysaccharide; LY86 variation was previously associated with VTE in white women; LOC100130298 is a non-coding RNA gene with unknown regulatory activity in gene expression and epigenetics.Supplementary Material to this article is available online at www.thrombosis-online.com.


2015 ◽  
Vol 23 ◽  
pp. 77-86 ◽  
Author(s):  
Román Vilas ◽  
Sara G. Vandamme ◽  
Manuel Vera ◽  
Carmen Bouza ◽  
Gregory E. Maes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document